Literature DB >> 19927515

Aggressive resection of hepatocellular carcinoma with right atrial involvement.

Sander Florman1, Michael Weaver, Paul Primeaux, Mary Killackey, Rafael Sierra, Santiago Gomez, Salima Haque, Fredric Regenstein, Luis Balart.   

Abstract

Hepatocellular carcinoma with extension into the right heart is a recognized, albeit rare occurrence. Patients who present with tumors extending into the heart have generally been considered inoperable and had limited survival, many sustaining tumor embolism and/or sudden death. Resection has been fraught with intraoperative and perioperative mortality as well as considerable postoperative morbidity. We report an exceptional case of a patient with such a tumor successfully treated with an aggressive surgical approach and review the limited published experience.

Entities:  

Mesh:

Year:  2009        PMID: 19927515

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  15 in total

1.  Intra-atrial tumor thrombi secondary to hepatocellular carcinoma responding to chemotherapy.

Authors:  Ajay Vallakati; Preeti A Chandra; Robert Frankel; Jacob Shani
Journal:  N Am J Med Sci       Date:  2011-09

2.  Hepatocellular Carcinoma With Intra-atrial Extension Responding to Transarterial Chemoembolization via the Right Hepatic and Right Inferior Phrenic Arteries.

Authors:  Maen W H Kamal; Maham Farshidpour; Andrew W Long; Saleem Farooqui; Steven C Cunningham
Journal:  Gastrointest Cancer Res       Date:  2014-05

Review 3.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.

Authors:  Kazuhiko Sakamoto; Hiroaki Nagano
Journal:  Surg Today       Date:  2017-12-26       Impact factor: 2.549

4.  Long-term survival after chemoembolization of metastatic right atrial tumor thrombus as a presenting feature of hepatocellular carcinoma: A case study.

Authors:  Jun-Hui Sun; Yue-Lin Zhang; Chun-Hui Nie; Li-Ming Chen; Jian-DI He; Wei-Lin Wang; Shu-Sen Zheng
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

5.  Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report.

Authors:  Pietro Gatti; Antonio Giorgio; Emanuela Ciracì; Italia Roberto; Alessandro Anglani; Spano Sergio; Fernando Rizzello; Valentina Giorgio; Stefano Semeraro
Journal:  J Ultrasound       Date:  2019-03-12

6.  Right Atrial Tumor Invasion: A Rare Presentation of Hepatocellular Carcinoma.

Authors:  Kathie Wu; Catherine E Travaline; Leighton Elliot
Journal:  Cureus       Date:  2022-03-06

7.  Concomitant Hepatectomy and Atrial Thrombectomy under Cardiopulmonary Bypass versus Staged Hepatectomy in the Treatment for Hepatocellular Carcinoma with Large Right Atrial Tumor Thrombi.

Authors:  Wen-Shan Chao; Ching-Hui Shen; Shao-Ciao Luo; Feng-Hsu Wu; Hao-Ji Wei; Chu-Leng Yu; Cheng-Chung Wu; Yun Yen; Fang-Ku P'eng
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

8.  Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis.

Authors:  Zhen-Hua Chen; Xiu-Ping Zhang; Shuang Feng; Jing-Kai Feng; Zong-Tao Chai; Wei-Xing Guo; Jie Shi; Wan Yee Lau; Yan Meng; Shu-Qun Cheng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-10       Impact factor: 8.265

Review 9.  Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Simone Conci; Alessandro Valdegamberi; Marco Vitali; Francesca Bertuzzo; Michela De Angelis; Guido Mantovani; Calogero Iacono
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

10.  Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.

Authors:  Kenji Wakayama; Toshiya Kamiyama; Hideki Yokoo; Tatsuhiko Kakisaka; Hirofumi Kamachi; Yosuke Tsuruga; Kazuaki Nakanishi; Tsuyoshi Shimamura; Satoru Todo; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2013-10-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.